Evoke Pharma Schedules Conference Call and Webcast for First Quarter 2017 Financial Results
May 01 2017 - 8:30AM
Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical
company focused on treatments for gastrointestinal diseases,
announced today that the Company will release financial results for
the first quarter ended March 31, 2017 on Monday, May 15, 2017,
after the market closes.
Evoke will hold a conference call on Monday, May
15, 2017 at 4:30 pm ET to discuss the results. Participants should
dial 1-877-407-0789 (United States) or 1-201-689-8562
(International) and mention Evoke Pharma. A live webcast of the
conference call will also be available on the investor relations
page of the Company's corporate website at www.evokepharma.com.
After the live webcast, the event will be
archived on Evoke's website for one year. In addition, a telephonic
replay of the call will be available until May 22, 2017. The replay
can be accessed by dialing 1-844-512-2921 (United States) or
1-412-317-6671 (International) with confirmation code 13660963.
About Evoke Pharma, Inc.
Evoke is a specialty pharmaceutical company focused primarily on
the development of drugs to treat GI disorders and diseases. The
Company is developing Gimoti, a metoclopramide nasal spray for the
relief of symptoms associated with acute and recurrent
gastroparesis in women with diabetes mellitus. Diabetic
gastroparesis is a GI disorder afflicting millions of sufferers
worldwide, in which the stomach takes too long to empty its
contents resulting in serious digestive system symptoms.
Metoclopramide is the only product currently approved in the United
States to treat gastroparesis, and is currently available only in
oral and intravenous forms. Gimoti is a novel formulation of this
drug, designed to provide systemic delivery of metoclopramide
through nasal administration. Visit www.EvokePharma.com for
more information.
Investor Contact:
The Ruth Group
Tram Bui
Tel: 646-536-7035
tbui@theruthgroup.com
Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Sep 2023 to Sep 2024